It has been shown that slight elevations of inflammatory markers are associated with an increased risk of non-small cell lung carcinoma (NSCLC) occurrence [11]–[12], and serum C-reactive protein (CRP) has been identified as a prognostic factor in both advanced and resectable NSCLC [13], [14]. The gene discussed is CRP; the disease is non-small cell lung carcinoma.